Does platelet activity play a role in the pathogenesis of idiopathic ischemic priapism?

Yavuz Ufuk1, Yilmaz Hasan1, Ustuner Murat1

  • 1Department of Urology, University of Kocaeli, Kocaeli, Turkey.

Abstract

Insights

Idiopathic ischemic priapism (IIP) patients show higher mean platelet volume (MPV), a marker of platelet reactivity. This suggests elevated MPV may contribute to IIP

Area of Science:

  • Urology
  • Hematology
  • Andrology

Background:

  • Mean platelet volume (MPV) indicates platelet size and reactivity.
  • Elevated MPV is a known risk factor for intravascular thrombosis.
  • Idiopathic ischemic priapism (IIP) involves veno-occlusive dysfunction.

Purpose of the Study:

  • To investigate the association between MPV and the veno-occlusive component of IIP.
  • To determine if MPV levels differ in patients with IIP compared to healthy controls.

Main Methods:

  • Retrospective analysis of 38 subjects (15 IIP patients, 23 controls) from 2010-2014.
  • Evaluation of complete blood count parameters including MPV, platelet count (PLT), WBC, RBC, Hb, PDW, and RDW.
  • Comparison of hematological parameters between IIP patients and healthy controls.

Main Results:

  • IIP patients exhibited significantly higher MPV compared to controls (p<0.05).
  • Platelet counts (PLT) were significantly lower in IIP patients versus controls (p<0.05).
  • Hemoglobin and WBC levels were lower in the control group; no significant differences in RBC, PDW, or RDW were observed.

Conclusions:

  • Significantly elevated MPV in IIP patients suggests a potential role in the disease's veno-occlusive etiopathogenesis.
  • High MPV may be a contributing factor to the development of IIP.
  • Further prospective studies are recommended to validate MPV's utility in routine clinical practice for IIP.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.5K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
590
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.5K